The Incidence of Gallstones After Gastrectomy
Study Details
Study Description
Brief Summary
To provide preventive and therapeutic strategies for participants with gallstones after gastric cancer by comparing the risk of postoperative gallbladder stone formation with two different resection ranges using the Roux-en-Y reconstruction modality in radical gastric cancer surgery.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
A large number of clinical studies have found that the incidence of gallstones in patients after radical gastric cancer surgery is higher than that in the normal population. However, the pathogenesis has not been clarified, and the prophylactic removal of the gallbladder in patients with gastric cancer remains controversial. A previous study found a statistically significant incidence of gallbladder stones after Billroth I versus Roux-en-Y in distal gastrectomy for gastric cancer. Therefore, the investigators plan to conduct a retrospected cohort study to collect further participants with gastric cancer who underwent total gastrectomy to answer whether different surgical resection ranges during surgery increase the incidence of gallstones this question.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Distal gastrectomy Distal subtotal gastrectomy was performed after exclusion of contraindications to surgery. Gastrointestinal reconstruction was performed by residual gastrojejunal Roux-en-Y anastomosis. Anastomosis was performed ex vivo or in vivo. |
Procedure: Distal gastrectomy and radical resection
Distal gastrectomy and Roux-en-Y anastomosis
|
Sham Comparator: Total gastrectomy Total gastrectomy was performed after the exclusion of contraindications to surgery. Gastrointestinal reconstruction was performed by oesophageal jejunum Roux-en-Y anastomosis. Anastomosis was performed ex vivo or in vivo. |
Procedure: Total gastrectomy and radical resection
Total gastrectomy and Roux-en-Y anastomosis
|
Outcome Measures
Primary Outcome Measures
- Number of gallstone patients [5years]
Two groups of patients with gastric cancer had a follow-up for more than one year and the number of patients with gallbladder stones on B-ultrasound or Computed Tomography (CT)
Secondary Outcome Measures
- Number of patients with postoperative complications [5years]
The number of patients with postoperative complications such as abdominal haemorrhage, fistula, nausea, vomiting, abdominal infection and incision infection in 2 groups of gastric cancer patients
- Number of patients with bile duct stones [5years]
Two groups of patients with gastric cancer had a follow-up for more than one year. Clinical signs such as Charcot's triad and ultrasound, Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) show the number of patients with bile duct stones
Eligibility Criteria
Criteria
Inclusion Criteria:
- Patients with Gastric Cancer underwent Gastrectomy
Exclusion Criteria:
-
Age less than 18 years or age greater than 75 years;
-
Not Roux-en-Y reconstruction;
-
R0 excision is not achieved;
-
Previous history of upper abdominal surgery, such as cholecystectomy, gastrectomy;
-
History of Endoscopic Submucosal Dissection (ESD) or Endoscopic Mucosal Resection (EMR);
-
Preoperative gallbladder diseases, such as gallstones, gallbladder polyps, chronic cholecystitis;
-
Preoperative neoadjuvant chemotherapy or radiotherapy;
-
Previous history of malignant tumours;
-
Patients with mental or developmental abnormalities or women during pregnancy or breastfeeding;
-
Gastric perforation or bleeding leading to emergency surgery;
-
Palliative surgical treatment;
-
Incomplete case information.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Hepatopancreatobiliary Surgery Institute of Gansu Province | Lanzhou | Gansu | China | 730000 |
2 | Wuwei Tumor Hospital | Wuwei | Gansu | China | 733099 |
Sponsors and Collaborators
- Hepatopancreatobiliary Surgery Institute of Gansu Province
Investigators
- Principal Investigator: Wenbo Meng, M.D., Hepatopancreatobiliary Surgery Institute of Gansu Province
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- GGBS